Surgical management of stem cell transplantation-related complications in children

Pediatric Transplantation
Justus LieberJörg Fuchs

Abstract

HSCT is an established treatment option for some children with life-threatening diseases, but complications remain a major cause of morbidity and mortality. This retrospective data analysis addresses the surgical issues of children with HSCT-related complications. Between 2002 and 2008, HSCT was performed in 240 children for leukemias/lymphomas (n=135), solid tumors (n=59), immunodeficiencies (n=20), lipid storage diseases (n=10), autoimmune diseases (n=9), and others (n=7). HSCT-related complications requiring surgery occurred in 24 cases (10%) and most often in the leukemias/lymphomas group (18/24 cases): HC (cystoscopic irrigation, n=7), pulmonary aspergilloses (resection, n=7), bone necroses (core decompression, n=3), GvHD bowel (colostomy/PEG, n=2), ICH (drainage, n=2), bilateral kidney abscess (nephrectomies/renal transplantation, n=1), aspergillosis of the maxillary sinus (decompression, n=1), and post-traumatic wound healing disorder (meshed skin transplantation, n=1). Survival was 50% in the group with surgery and 62% in the group without (p=0.275). Even though this difference was not statistically significant, surgical intervention should be encouraged in all cases to achieve favorable results.

References

Jul 24, 1986·The New England Journal of Medicine·R R ArthurR Saral
Jun 1, 1987·Journal of Pediatric Surgery·E S Golladay, S B Baker
May 1, 1995·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·A BediR J Jones
Sep 22, 1999·Bone Marrow Transplantation·A IguchiY Ishikawa
Dec 22, 1999·Journal of Neurology, Neurosurgery, and Psychiatry·C de BrabanderM J van den Bent
May 9, 2000·Cancer Treatment and Research·P J Henslee-Downey
May 18, 2000·American Journal of Hematology·M Furlan, B Lämmle
Jan 5, 2002·Hematology/oncology Clinics of North America·T G GrossF O Smith
Feb 9, 2002·The Annals of Thoracic Surgery·Dominique GossotPatricia Ribaud
Apr 2, 2002·Best Practice & Research. Clinical Haematology·P J Henslee-Downey
Sep 23, 2003·The Thoracic and Cardiovascular Surgeon·P MattH-R Zerkowski
Dec 13, 2005·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·David A JacobsohnMorris Kletzel
Apr 20, 2007·Annals of the New York Academy of Sciences·Rupert HandgretingerPeter Lang
Sep 18, 2007·Blood Cells, Molecules & Diseases·Ingo MüllerRupert Handgretinger
Feb 5, 2008·Pediatric Clinics of North America·Rupert HandgretingerR Maarten Egeler
Jul 24, 2008·Bone Marrow Transplantation·L M BallUNKNOWN EBMT Paediatric Working Party
Nov 26, 2008·Bone Marrow Transplantation·P Lang, R Handgretinger
Jun 16, 2009·Human Pathology·Kay Washington, Madan Jagasia
Mar 15, 2011·Best Practice & Research. Clinical Haematology·O Ringden, K Le Blanc

❮ Previous
Next ❯

Citations

Oct 18, 2015·International Journal of Surgery·Justus LieberJörg Fuchs
Sep 17, 2014·Pediatric Transplantation·Arin L MadenciChristopher B Weldon

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Aspergillosis

Aspergillosis is the name given to a wide variety of diseases caused by infection by fungi of the genus Aspergillus. Aspergillosis occurs in chronic or acute forms which are clinically very distinct. Most cases of acute aspergillosis occur in patients with severely compromised immune systems. Chronic colonization or infection can cause complications in people with underlying respiratory illnesses. Discover the latest research on aspergillosis here.

Aspergillosis (ASM)

Aspergillosis is the name given to a wide variety of diseases caused by infection by fungi of the genus Aspergillus. Aspergillosis occurs in chronic or acute forms which are clinically very distinct. Most cases of acute aspergillosis occur in patients with severely compromised immune systems. Chronic colonization or infection can cause complications in people with underlying respiratory illnesses. Discover the latest research on aspergillosis here.